These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 28811713)
1. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. Guadagni F; Riondino S; Formica V; Del Monte G; Morelli AM; Lucchetti J; Spila A; D'Alessandro R; Della-Morte D; Ferroni P; Roselli M World J Gastroenterol; 2017 Jul; 23(28):5187-5195. PubMed ID: 28811713 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of glycated hemoglobin in colorectal cancer. Ferroni P; Formica V; Della-Morte D; Lucchetti J; Spila A; D'Alessandro R; Riondino S; Guadagni F; Roselli M World J Gastroenterol; 2016 Dec; 22(45):9984-9993. PubMed ID: 28018105 [TBL] [Abstract][Full Text] [Related]
3. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study. Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674 [TBL] [Abstract][Full Text] [Related]
5. Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case-control study. R Charlier SH; Meier C; Jick SS; Meier CR; Becker C Cardiovasc Diabetol; 2022 Jan; 21(1):2. PubMed ID: 34983504 [TBL] [Abstract][Full Text] [Related]
6. Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer. Parker A; Peterson E; Lee AYY; de Wit C; Carrier M; Polley G; Tien J; Wu C J Thromb Haemost; 2018 Jul; 16(7):1321-1326. PubMed ID: 29733498 [TBL] [Abstract][Full Text] [Related]
7. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer. Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188 [TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis. Di Nisio M; Candeloro M; Rutjes AWS; Porreca E J Thromb Haemost; 2018 Jul; 16(7):1336-1346. PubMed ID: 29754426 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. Van Schouwenburg IM; Mahmoodi BK; Veeger NJ; Bakker SJ; Kluin-Nelemans HC; Meijer K; Gansevoort RT J Thromb Haemost; 2012 Jun; 10(6):1012-8. PubMed ID: 22443091 [TBL] [Abstract][Full Text] [Related]
10. Low rates of symptomatic venous thromboembolism in patients with gastrointestinal cancer: an Iranian study. Mortazavizadeh M; Ayoughi Y; Bashardoost N; Fadavi P Blood Coagul Fibrinolysis; 2017 Jul; 28(5):351-355. PubMed ID: 27661390 [TBL] [Abstract][Full Text] [Related]
11. Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study. Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Cho YK; Kim YB BMC Cancer; 2021 Oct; 21(1):1166. PubMed ID: 34717579 [TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy. Marshall-Webb M; Bright T; Price T; Thompson SK; Watson DI Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27878904 [TBL] [Abstract][Full Text] [Related]
13. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Di Nisio M; Porreca E; Otten HM; Rutjes AW Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736 [TBL] [Abstract][Full Text] [Related]
14. Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study. Douce DR; Holmes CE; Cushman M; MacLean CD; Ades S; Zakai NA J Thromb Haemost; 2019 Dec; 17(12):2152-2159. PubMed ID: 31423717 [TBL] [Abstract][Full Text] [Related]
15. Venous Thromboembolism Is an Independent Predictor of Mortality Among Patients with Gastric Cancer. Fuentes HE; Oramas DM; Paz LH; Wang Y; Andrade XA; Tafur AJ J Gastrointest Cancer; 2018 Dec; 49(4):415-421. PubMed ID: 28634671 [TBL] [Abstract][Full Text] [Related]
16. Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial. Mandalà M; Barni S; Prins M; Labianca R; Tondini C; Russo L; Milesi A; Cremonesi M; Zaccanelli M; Regonesi C; Moro C; Falanga A Ann Oncol; 2010 Apr; 21(4):871-876. PubMed ID: 19713246 [TBL] [Abstract][Full Text] [Related]
17. TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy. Roselli M; Ferroni P; Rolfo C; Peeters M; Palmirotta R; Formica V; Ludovici G; Laudisi A; De Marchis ML; La Farina F; Russo A; Guadagni F Ann Oncol; 2013 Oct; 24(10):2571-2575. PubMed ID: 23852308 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of HDL cholesterol for cancer-associated venous thromboembolism during chemotherapy. Ferroni P; Roselli M; Riondino S; Guadagni F J Thromb Haemost; 2014 Dec; 12(12):2049-53. PubMed ID: 25256037 [TBL] [Abstract][Full Text] [Related]
19. Association of pathologic factors with postoperative venous thromboembolism after gastrointestinal cancer surgery. Janczewski LM; Silver CM; Schlick CJR; Odell DD; Bentrem DJ; Yang AD; Bilimoria KY; Merkow RP J Gastrointest Surg; 2024 Jun; 28(6):813-819. PubMed ID: 38553295 [TBL] [Abstract][Full Text] [Related]
20. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy. Basaran D; Boerner T; Suhner J; Sassine D; Liu Y; Grisham RN; Tew WP; Gardner GJ; Zivanovic O; Sonoda Y; Long Roche K; Chi DS; Abu-Rustum NR; Soff GA; Jewell EL Gynecol Oncol; 2021 Oct; 163(1):36-40. PubMed ID: 34312001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]